Meetings & Events

Insulin 2121: The Next 100 Years of Discoveries

August 11, 2021

The Society's free half-day educational event on the future of insulin featured top researchers and clinicians discussing the technology and therapies that will transform the field over the next 100 years. Research into robots that would automate routine tasks and free up clinicians’ time, next-gen glucagon, and weekly insulin injections were just a few of the innovative topics discussed. Watch the full webinar for free.


Program

Part I: Cellular and Biological Advances in Type 1 Diabetes

11:00-11:10AM   Introduction
11:10-11:30AM Current understanding and opportunities in type 1 diabetes 
11:30-11:50AM Future Treatment Options: Islet Cell Transplantation 
11:50AM-12:10PM           Q&A
12:10-12:20PM Break

Speakers:

Carol Wysham, MD
University of Washington
Introduction

Alvin Powers, MD
Vanderbilt University Medical Center
Current understanding and opportunities in type 1 diabetes

Doug Melton, PhD
Harvard University
Future Treatment Options: Islet Cell Transplantation 

Part II: Advances in Pharmacotherapy

12:20-12:35PM         Once-a-Week Insulin: An Equally Effective Treatment for Type 2 Diabetes
12:35-12:50PM The Potential of Next-gen Glucagon for Severe Hypoglycemia
12:50-1:05PM Insulin Therapies That Will Change the Game for Patients with Diabetes 
1:05-1:20PM      Q&A

Speakers:

Juan Pablo Frias, MD, PhD
National Research Institute
Once-a-Week Insulin: An Equally Effective Treatment for Type 2 Diabetes

Elizabeth Seaquist, MD
University of Minnesota
The Potential of Next-gen Glucagon for Severe Hypoglycemia

Yogish Kudva, MD
Mayo Clinic 
Insulin Therapies That Will Change the Game for Patients with Diabetes

Part III: Insulin Technology and Future Delivery Models

1:20-1:30PM           Break
1:30-1:45PM What Advances are Next for CGM?
1:45-2:00PM   Breakthroughs in the Artificial Pancreas 
 2:00-2:15PM Robots, Drones and AI in Diabetes Care
2:15-2:30PM      Q&A

Speakers:

Anne Peters, MD
University of Southern California
What Advances are Next for CGM?

Steven Russell, MD, PhD
Massachusetts General Hospital
Breakthroughs in the Artificial Pancreas

Derek O'Keeffe, MD, PhD, FRCPI
National University of Ireland Galway
Robots, Drones and AI in Diabetes Care


With Support From

Last Updated:
Back to top

Who We Are

For 100 years, the Endocrine Society has been at the forefront of hormone science and public health. Read about our history and how we continue to serve the endocrine community.